CSTL
CASTLE BIOSCIENCES INC
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$32.17
+0.64%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.09x
- Price / sales
- 2.75x
- Price / cash flow
- 23.05x
Enterprise value
- Enterprise value
- $752.5M
- EV / sales
- 2.11x
- EV / EBITDA
- -232.53x
- EV / EBIT
- -23.44x
- Market cap
- $982.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026